台華新材(603055.SH):擬不低於120億元投建綠色多功能錦綸新材料一體化項目
格隆匯10月27日丨台華新材(603055.SH)公佈,根據公司戰略規劃和長遠發展,公司擬與淮安市洪澤區人民政府簽署《投資協議書》,在淮安市洪澤區新建綠色多功能錦綸新材料一體化項目,總投資不低於120億元,其中固定資產投資不低於105億元。項目分四期建設,計劃5年內建成:第一期為年產10萬噸再生差別化錦綸絲項目和6萬噸PA66差別化錦綸絲項目,第二期為年產6萬噸PA66差別化錦綸絲項目、3億米錦綸坯布項目和1億米染整項目,第三期為年產20萬噸PA6差別化錦綸絲項目、3億米錦綸坯布項目和1億米染整項目,第四期為年產20萬噸PA6差別化聚合項目。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.